MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility.

By M. Nikiforova, George C. Tseng, D. Steward, D. Diorio, Y. Nikiforov. Journal of Clinical Endocrinology and Metabolism, 2008

611 citations recorded by the source corpus.

Subfields: Cancer Research, Endocrinology, Diabetes and Metabolism

View Paper: https://www.semanticscholar.org/paper/b12eef69c75d8c63a631e7d48d884027c32ee64b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. Gianpiero di Leva
2. M. Garofalo
3. Carlo Maria Croce
4. George A. Calin
5. Marilena V. Iorio
6. Manel Esteller

In Endocrinology, Diabetes and Metabolism

1. Y. Nikiforov
2. M. Nikiforova

Citations in the corpus

• microRNAs in cancer (2013, background): “The miR-155 gene is overexpressed in several solid tumors—for example, in breast cancer (38, 77), colon cancer (38), cervical cancer (128), pancreatic ductal adenocarcinoma (129), thyroid carcinoma (130), and lung cancer (131)—where it is considered a marker of poor prognosis.”
• Molecular genetics and diagnosis of thyroid cancer (2011, background): “Generally, miRNA expression profiles of papillary carcinoma are different from those of follicular carcinoma and other thyroid tumors”
• miR-155 gene: a typical multifunctional microRNA. (2009, background): “Several studies have recently assessed the miRNA expression profiles of different types of thyroid cancer [50, 58-61].”